Supernus Pharmaceuticals (SUPN) CMO Rubin exercises PSUs and withholds shares for tax
Rhea-AI Filing Summary
SUPERNUS PHARMACEUTICALS, INC. senior vice president and chief medical officer Jonathan Rubin reported equity award activity involving Performance Share Units and common stock. On August 12, 2026, 750 Performance Share Units were exercised and converted into 750 shares of common stock at a conversion price of $0.00 per share, following the achievement of individual performance objectives described in an award granted on February 19, 2025 and performance objectives established on May 3, 2025.
Of the common shares underlying this vesting, 363 shares of common stock were withheld by the company at a price of $46.57 per share to satisfy tax withholding requirements related to the vesting. Footnote disclosure also states that the reporting person’s direct holdings include an aggregate of 251 shares acquired through the issuer’s Employee Stock Purchase Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 387 shares
Net Buy
3 txns
Insider
Rubin Jonathan
Role
SVP, Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Share Unit F3 | 750 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 750 | $0.00 | $0.00 |
| Tax Withholding | Common Stock F2 | 363 | $46.57 | $17K |
Holdings After Transaction:
Performance Share Unit — 0 shares (Direct);
Common Stock — 13,979 shares (Direct)
Footnotes (3)
- F1. Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
- F2. Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.
- F3. On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.
Key Figures
Performance Share Units exercised: 750 units
Common shares acquired from PSU vesting: 750 shares
Shares withheld for tax withholding: 363 shares
+4 more
7 metrics
Performance Share Units exercised
750 units
Performance Share Units converted into common stock on August 12, 2026
Common shares acquired from PSU vesting
750 shares
Shares of common stock received upon PSU conversion on August 12, 2026
Shares withheld for tax withholding
363 shares
Common stock withheld by company to satisfy tax withholding requirements
Tax withholding share price
$46.57 per share
Price used for shares withheld to satisfy tax withholding obligations
ESPP shares included in holdings
251 shares
Aggregate shares acquired through Employee Stock Purchase Plan included in holdings
PSU award grant date
February 19, 2025
Grant date of Performance Share Units that later vested and converted
Performance objectives established date
May 3, 2025
Date individual performance objectives for the PSU award were established
Key Terms
Performance Share Units, Employee Stock Purchase Plan, tax withholding requirements, derivative security
4 terms
Employee Stock Purchase Plan financial
"Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
tax withholding requirements financial
"withheld by the Company to satisfy tax withholding requirements in connection with the vesting"
derivative security financial
"transaction_code_description":"Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What did SUPN executive Jonathan Rubin report in this Form 4 transaction?
Jonathan Rubin reported the exercise of 750 Performance Share Units into 750 shares of Supernus Pharmaceuticals common stock on August 12, 2026, with part of the resulting shares withheld by the company to cover tax withholding requirements.
What additional holdings detail is disclosed for SUPN’s Jonathan Rubin?
A footnote states that Rubin’s direct holdings include 251 shares acquired through Supernus Pharmaceuticals’ Employee Stock Purchase Plan. This provides context on part of his existing common stock position but not a complete total holding figure.
Were SUPN Form 4 transactions by Jonathan Rubin under a Rule 10b5-1 plan?
The Form 4 indicates the document-level Rule 10b5-1 checkbox is not affirmatively checked. The footnotes describing these Performance Share Unit transactions do not state that they were executed pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
